Preservation of ovarian function during chemotherapy and radiotherapy in young women with malignancies

Iranian Journal of Reproductive Medicine

Volumn 12, Issue 6, 2014, Pages 377-382

  Eftekhar, Maryam ^a   Pourmasumi, Soheila ^a   Karimi Zarchi, Mojgan ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cervical cancer; Endometrial cancer; Fertility preservation; Leukemia; Malignancy; Ovarian cancer

Indexed keywords

ANTINEOPLASTIC AGENT; GONADORELIN; GONADORELIN AGONIST; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; TAMOXIFEN;

ARTICLE; BORDERLINE OVARY TUMOR; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONSERVATIVE TREATMENT; EARLY DIAGNOSIS; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FERTILITY PRESERVATION; GERM CELL OVARY CARCINOMA; HUMAN; HYSTERECTOMY; INFERTILITY THERAPY; LEUKEMIA; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARY CANCER; OVARY CARCINOMA; OVARY FUNCTION; PELVIS LYMPHADENECTOMY; RADICAL VAGINAL TRACHELECTOMY; RECURRENCE RISK; SALPINGOOOPHORECTOMY; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; UTERINE CERVIX CANCER; UTERUS SURGERY;

EID: 84916641101     PISSN: 16806433     EISSN: 20082177     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Wallace W, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol2005; 6: 209.
2. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol2006; 24: 2917-2931.
3. Loscalzo MJ, Clark KL. The psychosocial context of cancer-related infertility. Cancer Treat Res2007; 138: 180-190.
4. Colombo N, Parma G, Lapresa M, Maggi F, Piantanida P, Maggioni A. Role of conservative surgery in ovarian cancer: the European experience. Int J Gynecol Cancer2005; 15: 206-211.
5. Maneo A, Chiari S, Bonazzi C, Mangioni C. Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer. Gynecol Oncol2008; 111: 438-443.
6. Tangir J, Zelterman D, Ma W, Schwartz PE. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstet Gynecol2003; 101: 251-257.
7. Makar AP, Tropé C. Fertility preservation in gynecologic cancer. Acta Obstet Gynecol Scan 2001; 80: 794-802.
8. Rodriguez-Wallberg KA, Oktay K. Options on fertility preservation in female cancer patients. Cancer Treatment Rev2012; 38: 354-361.
9. Karimi-Zarchi M, Forat-Yazdi M, Vafaeenasab MR, Nakhaie-Moghadam M, Miratashi-Yazdi A, Teimoori S, et al. Evaluation of the effect of GnRH agonist on menstrual reversein breast cancer cases treated with cyclophosphamide. Eur J Gynaecol Oncol2014; 35: 59-61
10. Dursun P, LeBlanc E, Nogueira MC. Radical vaginal trachelectomy (Dargent's operation): a critical review of the literature. Eur J Surg Oncol2007; 33: 933-941
11. Burnett AF, Roman LD, O’Meara AT, Morrow CP. Radical vaginal trachelectomy and pelvic lymphadenectomy for preservation of fertility in early cervical carcinoma. Gynecol Oncol2003; 88: 419-423.
12. Zarchi MK, Mousavi A, Gilani MM, Barooti E, Rad OA, Ghaemmaghami F, et al. Fertility Sparing Treatments in Young Patients with Gynecological Cancers: Iranian Experience and Literature. Asian Pac J Cancer Prev2011; 12: 1887-1892
13. Mathevet P, Laszlo DKE, Dargent D. Fertility preservation in early cervical cancer. Gynecol Obstet Fertil 2003; 31: 706-712. (In French)
14. Plante M, Renaud M-C, Hoskins IA, Roy M. Vaginal radical trachelectomy: a valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature. Gynecol Oncol2005; 98: 3-10.
15. Schlaerth JB, Spirtos NM, Schlaerth AC. Radical trachelectomy and pelvic lymphadenectomy with uterine preservation in the treatment of cervical cancer. Am J Obstet Gynecol2003; 188: 29-34.
16. Plante M, Renaud M-C, François H, Roy M. Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literature. Gynecol Oncol2004; 94: 614-623.
17. Hertel H, Kohler C, Grund D, Hillemanns P, Possover M, Michels W, et al. Radical vaginal trachelectomy (RVT) combined with laparoscopic pelvic lymphadenectomy: prospective multicenter study of 100 patients with early cervical cancer. Gynecol Oncol2006; 103: 506-511.
18. Marie P, Harel F, Michel R. Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literature. Gynecol Oncol 2004; 94: 614-623.
19. Weed Jr JC, Graff AT, Shoup B, Tawfik O. Small cell undifferentiated (neuroendocrine) carcinoma of the uterine cervix. J Am Coll Surg2003; 197: 44-51.
20. Beth S, Stephanie J.L, Ann H.P, Carolyn D. R. Preserving Fertility After Cancer: A Cancer, Journal for Clinicians 2005; 55: 211-228.
21. Covens A, Rosen B, Murphy J, Laframboise S, DePetrillo A, Lickrish G, et al. Changes in the demographics and perioperative care of stage IA(2)/ IB(1) cervical cancer over the past 16 years. Gynecol Oncol2001; 81: 133-137.
22. Donnez J, Kim SS. Principles and practice of fertility preservation. Cambridge university press; New york.2011.
23. Fagotti A, Gagliardi ML, Moruzzi C, Carone V, Scambia G, Fanfani F. Excisional cone as fertility-sparing treatment in early-stage cervical cancer. Fertil Steril2011; 95: 1109-1112.
24. Karimi-Zarchi M, Mousavi A, Gilani MM, Barooti E, Miratashi-Yazdi A, Dehghani A. Conservative treatment in early cervical cancer. Int J Biomed Sci2013; 9: 123-128.
25. Karimi-Zarchi M, Mousavi A, Dehghani A. Conservative surgery in cervical cancer: report of two radical abdominal trachelectomies and literature review. Eur J Gynaecol Oncol2011; 32: 710-712.
26. Plante M. Fertility preservation in the management of gynecologic cancers. Cur Opin Oncol2000; 12: 497-507.
27. Kimmig R, Strowitzki T, Moller-Höcker J, Kürzl R, Korell M, Hepp H.Conservative treatment of endometrial cancer permitting subsequent triplet pregnancy. Gynecol Oncol1995; 58: 255-257.
28. Emons G, Fleckenstein G, Hinney B, Huschmand A, Heyl W. Hormonal interactions in endometrial cancer. Endocr Relat Cancer2000; 7: 227-242.
29. Balen A. Polycystic ovary syndrome and cancer. Hum Reprod Update2001; 7: 522-525.
30. Wang CB, Wang CJ, Huang HJ, Hsueh S, Chou HH, Soong YK, et al. Fertility‐preserving treatment in young patients with endometrial adenocarcinoma. Cancer2002; 94: 2192-2198.
31. Liou W-S, Yap OS, Chan JK, Westphal LM. Innovations in fertility preservation for patients with gynecologic cancers. Fertil Steril2005; 84: 1561-1573.
32. Rackow BW, Arici A. Endometrial cancer and fertility. Cur Opin Obstet Gynecol2006; 18: 245.
33. Gallos ID, Yap J, Rajkhowa M, Luesley DM, Coomarasamy A, Gupta JK. Regression, relapse and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol2012; 207: 1-12.
34. Thigpen JT, Brady MF, Alvarez RD, Adelson MD, Homesley HD, Manetta A, et al. Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. J Clin Oncol1999; 17: 1736-1744.
35. Karimi-Zarchi M, Mousavi AS, Behtash N, Chiti Z, Bokaie M. Conservative management of young women with endometrial carcinoma or complex atypical hyperplasia: report of three cases and literature review. Eur J Gynaecol Oncol2011; 32: 695-698.
36. Kokka F, Brockbank E, Oram D, Gallagher C, Bryant A. Hormonal therapy in advanced or recurrent endometrial cancer. Cochrane Database Syst Rev 2010; 12: CD007926.
37. Montz FJ, Bristow RE, Bovicelli A, Tomacruz R, Kurman RJ. Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol2002; 186: 651-657.
38. Rubin SC, Sutton GP. Ovarian cancer: Lippincott Williams & Wilkins; 2001.
39. Wright JD, Shah M, Mathew L, Burke WM, Culhane J, Goldman N, et al. Fertility preservation in young women with epithelial ovarian cancer. Cancer2009; 115: 4118-4126.
40. Duska LR, Chang Y, Flynn CE, Chen AH, Goodman A, Fuller AF, et al. Epithelial ovarian carcinoma in the reproductive age group. Cancer1999; 85: 2623-2629.
41. Winter III WE, Maxwell GL, Tian C, Carlson JW, Ozols RF, Rose PG, et al. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol2007; 25: 3621-3627.
42. Chi DS, Liao JB, Leon LF, Venkatraman ES, Hensley ML, Bhaskaran D, et al. Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol2001; 82: 532-537.
43. Karimi Zarchi M, Mousavi A, Gilani MM, Barooti E, Amini Rad O, Ghaemmaghami F, et al. Fertility sparing treatments in young patients with gynecological cancers: Iranian experience and literature review. Asian Pac J Cancer Prev2011; 12: 1887-1892.
44. Thigpen T, Brady MF, Omura GA, Creasman WT, Mcguire WP, Hoskins WJ, et al. Age as a prognostic factor in ovarian carcinoma: The Gynecologic Oncology Group experience. Cancer1993; 71: 606-614.
45. Seli E, Tangir J. Fertility preservation options for female patients with malignancies. Cur Opin Obstet Gynecol2005; 17: 299-308.